Mobile production units for the anti-Covid vaccine soon to be sent to Africa

A dose of Pfizer vaccine.

Robyn BeckAFP/Archivos

Text by: RFI Follow

1 min

BioNTech, the German lab behind Pfizer's messenger RNA vaccine, has unveiled two twelve-container modules that will be installed in Rwanda or Senegal and possibly in both countries to manufacture the vaccine locally.

Advertising

Read more

This mobile plant will be sent on site from the second quarter of this year, the first doses should be available twelve months later.

Opening a conventional factory of this type normally takes three years.

The challenge, explains the CEO of BioNtech, was to make the manufacturing process compact enough to fit in a single container, the idea being to standardize the 50,000 or so steps required before obtaining the vaccine.

Employees of the BioNTech laboratory will work on site at the start and then train local specialists in order to “ 

 ”.

It is therefore a transfer of certain technologies, but without the lifting of patents demanded in particular by many developing countries and NGOs.

After Rwanda and Senegal, South Africa could be the next country to join this production network.

Africa is the least vaccinated continent.

More than a year after the administration of the first vaccines against Covid-19 and two years after the start of the pandemic, only 12% of Africans have been fully immunized.

Newsletter

Receive all the international news directly in your mailbox

I subscribe

Follow all the international news by downloading the RFI application

google-play-badge_FR

• Rwanda

• Coronavirus

• Senegal

• Africa

• Technology